Variables

n = 75 patients

Age, yrs (mean ± SD)

27.46 ± 17.11 (range 7 months to 80 yrs)

Sex (male/female)

2.26/1.0

Fever, n (%)

69 (92.0%)

Peripheral signs

Splenomegaly, n (%)

35 (46.7%)

Clubbing, n (%)

36 (48.0%)

Osler’s node, n (%)

5 (6.7%)

Roths spots, n (%)

7 (9.3%)

Splinter haemorrhage, n (%)

7 (9.3%)

Petechial haemorrhage, n (%)

6 (8.0%)

Janeway lesion, n (%)

3 (4.0%)

Complications

Cardiac complications

Congestive heart failure

(CHF), n (%)

32 (42.7%)

Conduction abnormalities (CHB, AV block), n (%)

5 (6.7%)

Pericardial effusion, n (%)

3 (4.0%)

Neurological complications

CV stroke, n (%)

15 (20.0%)

CNS haemorrhage, n (%)

4 (5.3%)

Mycotic aneurysm, n (%)

2 (2.7%)

Encephalopathy, n (%)

4 (5.3%)

Renal failure, n (%)

20 (26.7%)

Hepatic dysfunction, n (%)

17 (22.7%)

Embolism

Brain (CV stroke), n (%)

15 (20.0%)

Extremities (digital infarcts), n (%)

3 (4.0%)

Septic pulmonary infarct, n (%)

1 (1.3%)

Splenic infarct, n (%)

1 (1.3%)

Renal infarct, n (%)

1 (1.3%)

Septicaemia, n (%)

20 (26.7%)

Laboratory parameters

Hemoglobin (<12 gm %), n (%)

72 (96.0%)

ESR (≥20 mm), n (%)

72 (96.0%)

Leucocytosis (>11,000/mm³), n (%)

53 (70.7%)

Leucopenia (<4000/mm³), n (%)

2 (2.7%)

Thrombocytopenia, n (%)

21 (28.0%)

Microscopic haematuria, n (%)

31 (41.3%)

Elevated CRP, n (%)

70 (93.3%)

Positive RA factor, n (%)

9 (12.0%)